BlackRock Fund Advisors’s Tenax Therapeutics TENX Stock Holding History

BlackRock Fund Advisors’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$123K	Hold	2	–	–	﹤0.01%	3553
2016 Q3	$141K	Hold	2	–	–	﹤0.01%	3554
2016 Q2	$156K	Hold	2	–	–	﹤0.01%	3545
2016 Q1	$127K	Hold	2	–	–	﹤0.01%	3598
2015 Q4	$218K	Hold	2	–	–	﹤0.01%	3497
2015 Q3	$191K	Hold	2	–	–	﹤0.01%	3478
2015 Q2	$241K	Hold	2	–	–	﹤0.01%	3455
2015 Q1	$211K	Hold	2	–	–	﹤0.01%	3468
2014 Q4	$265K	Hold	2	–	–	﹤0.01%	3402
2014 Q3	$281K	Hold	2	–	–	﹤0.01%	3354
2014 Q2	$260K	Buy	+2	New	+$308K	﹤0.01%	3397

Other funds holding TENX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Fund Advisors's TENX Position: Q4 2016 in Review

BlackRock Fund Advisors held its Tenax Therapeutics (TENX) position steady in Q4 2016 at 2 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #3553.

BlackRock Fund Advisors first reported a position in TENX in Q2 2014 and has held it in 11 quarters since. The position peaked at $281K in Q3 2014. 19 funds tracked by Wall St. Rank hold TENX as of Q4 2016.

BlackRock Fund Advisors held 2 shares of Tenax Therapeutics worth $123K as of Q4 2016.
BlackRock Fund Advisors left its Tenax Therapeutics share count unchanged in Q4 2016.
Tenax Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3553 holding.
BlackRock Fund Advisors first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Tenax Therapeutics position peaked at $281K in Q3 2014.
19 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.